Nurix Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Nov2019 Nov2020 Nov2021 Nov2022 Nov2023 Nov2024
Operating Activities
Net Income -21.70M-43.20M-117.19M-180.36M-143.95M-193.57M
Share-based Compensation 0.51M4.30M15.80M28.13M33.67M33.93M
Gains from Investment Securities 0.10M3.40M5.07M24.00M4.11M
Non-cash Items 0.76M141.25M57.90M
Cash from Operations 0.60M-0.08M-84.36M-159.81M-81.36M-172.58M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.11M-0.27M3.29M5.46M6.12M11.29M
Depreciation & Amortization (CF) 2.40M2.20M2.80M5.35M7.53M9.32M
Change in Working Capital
Change in Receivables 6.00M-6.00M
Change in Account Payables 0.30M1.23M1.59M0.09M1.61M5.21M
Change in Accured Expenses 2.37M2.28M6.22M7.49M3.12M11.82M
Change in Taxes 3.85M-3.64M
Investing Activities
Capital Expenditures 1.65M4.55M5.66M12.24M8.40M9.27M
Change in Acquisitions & Divestments 19.50M25.37M238.91M278.81M323.04M459.51M
Cash from Investing Activities 8.50M-254.40M-108.25M27.20M68.30M-257.71M
Financing Activities
Change in Capital Stock
Shares Issued 0.14M218.15M150.16M94.76M2.23M289.76M
Preferred Shares Issued 119.91M
Misc.
Cash from Financing Activities 0.13M339.02M153.88M117.19M3.22M485.67M
Change in Cash 9.22M84.54M-38.73M-15.42M-9.85M55.37M
Free Cash Flow -1.05M-4.63M-90.03M-172.05M-89.77M-181.86M
Net Cash Flow 9.22M84.54M-38.73M-15.42M-9.85M55.37M